El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) ROCE %: 43.79% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:NIPH El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH
28 GF Score
Price E£184.90
! 9 Warning Signs
View Full Analysis

What is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ROCE %?

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH +4.93% 28 ROCE % is 43.79% as of Mar. 2026. GuruFocus rates CAI:NIPH with a GF Score™ of 28/100. The stock has 9 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's annualized ROCE % for the quarter that ended in Mar. 2026 was 43.79%.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile  (CAI:NIPH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ROCE % Related Terms

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ROCE % Historical Data

* Premium members only.

The historical data trend for El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ROCE % Chart

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Annual Data
Trend Jun24 Jun25
ROCE %
0.00 20.94

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial 0.00 9.26 54.24 40.26 43.79
CAI:NIPH
28GF Score
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ROCE % Calculation

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=234.164/( ( (0 - 0) + (2320.709 - 1202.195) )/ 1 )
=234.164/( (0+1118.514)/ 1 )
=234.164/1118.514
=20.94 %

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=677.16/( ( (2827.768 - 1286.39) + (3054.737 - 1503.271) )/ 2 )
=677.16/( ( 1541.378 + 1551.466 )/ 2 )
=677.16/1546.422
=43.79 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 43.79% mean?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a ROCE % of 43.79% as of Mar. 2026.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's ROCE % too high?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current ROCE % is 43.79%. The Drug Manufacturers industry median ROCE % is 7.04. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's value of 43.79% is 522% above this industry median. Overall, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's ROCE % compare to ZTS and UTHR?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's ROCE % of 43.79% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.04. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's value of 43.79% is 522% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current ROCE % of 43.79% is 522% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current ROCE % is 43.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile stock overvalued right now?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a current ROCE % of 43.79%. The current ROCE % is 43.79% and 522% above the Drug Manufacturers industry median of 7.04. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's overall GF Score™ is 28/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH), the current ROCE % is 43.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Business Description

Address Al-Sawah square, ElAmeria, Cairo, EGY
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile manufactures and markets pharmaceuticals, medicinal materials, chemical products and surgical threads and medical solutions.
28GF Score

Get the complete analysis for CAI:NIPH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£184.90
Price